Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
about
Tobacco harm reduction: an alternative cessation strategy for inveterate smokersNon-cigarette tobacco products: what have we learnt and where are we headed?Debunking the claim that abstinence is usually healthier for smokers than switching to a low-risk alternative, and other observations about anti-tobacco-harm-reduction argumentsPermissive nicotine regulation as a complement to traditional tobacco controlEthical considerations of e-cigarette use for tobacco harm reductionIs smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studiesNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?First, tell the truth: a dialogue on human rights, deception, and the use of smokeless tobacco as a substitute for cigarettes.Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.The feasibility of smoking reduction: an update.The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies.US smokers' reactions to a brief trial of oral nicotine productsTobacco smoking using a waterpipe: a re-emerging strain in a global epidemicCigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.Apply federal research rules on deception to misleading health information: an example on smokeless tobacco and cigarettesPrograms and policies to discourage the use of tobacco products.Estimating the health consequences of replacing cigarettes with nicotine inhalers.The US tobacco control community's view of the future of tobacco harm reduction.Community tobacco control leaders' perceptions of harm reduction.Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South AfricaTobacco harm reduction: what do the experts think?Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?"Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product.Deficiencies in public understanding about tobacco harm reduction: results from a United States national surveyProtocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokersAssociation between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes.Current and emerging pharmacotherapies for treating tobacco dependence.Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.Modeling flight attendants' exposure to secondhand smoke in commercial aircraft: historical trends from 1955 to 1989.Environmental Smoking Restrictions and Light Cigarette Adoption Among Chinese Urban Smokers.The time for tobacco industry sponsored PREP evaluation has arrived.Reducing harm from tobacco use.Promoting health (implicitly)? A longitudinal content analysis of implicit health information in cigarette advertising, 1954-2003.Philip Morris' FDA gambit: good for public health?Estimating the health impacts of tobacco harm reduction policies: a simulation modeling approach.Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine.Reducing toxicity exposure for the nicotine-dependent.Perceptions of the health risks related to cigarettes and nicotine among university faculty
P2860
Q21093267-C805C8B1-4EB0-41A4-A5B5-0E5C45CA992DQ24597316-E5891411-3CA3-443C-A09A-1122555F2F2CQ24657719-D3F9A8C8-056B-4310-9E85-12C86DE2C0EDQ24802184-0D495301-B394-4126-B40F-AE7F7EEB45B5Q26749334-E99BA04F-9150-499D-8E04-A2734BBD7342Q28266074-A8973DCB-40D9-4AE3-AABC-332CC6D6C22DQ28277165-2D3FFAE2-8E56-49C3-80A2-857906F9BB19Q30478671-CCE8E412-476B-4905-8EFF-DD99CBB672D0Q34366802-4E8ED821-0AF1-457A-8E9F-277342461C65Q34493167-EB85C02B-9AE8-4DE6-8F6F-11002C281105Q34494668-27E451AB-B2B4-45B4-85C3-E0283359CA90Q34547232-FD63D927-0F0F-4C92-95C6-5CDB98C271C7Q34552853-1C15F9DC-8D91-402C-8DFF-906D7EC5723DQ34563489-81A0CC50-8C21-42A3-8A58-C24C55960FE7Q34756200-D39D2395-393C-4A01-92B6-DDB4A6D6C2AFQ34963498-92AFE87A-627A-4915-B5FA-A78EBE08B3BDQ35538542-76C32B65-5270-4BE2-AF4F-31236025DD11Q35538729-BB4D0F3A-950B-4929-9E11-8031A9ECEA68Q35538945-D2EEA501-79ED-44D1-B077-A3D7926817D4Q35538959-F71C2C15-B893-4D2F-BC06-CC8F44EE3CA9Q35538999-6770B078-D86A-4526-B6E5-6D45B4AF0166Q35539487-4AFBA98B-A7A3-400A-A927-D9E9A4196EA7Q35578029-61C04764-BC89-43D0-828E-761A7A5EA467Q35806606-DBC81D3A-0CB4-4A2C-BCC9-2E7354BE4AA0Q36131179-20BB2E20-1B5E-440F-849A-7BEF278CD1CDQ36277984-D770EC44-2E73-4D4E-AE74-C355631762C4Q36580581-C93837CD-6B7C-45D6-8352-98B766E6C664Q38375230-E6B16E12-FC31-4425-8DD5-0DE32F0C8634Q39058897-99ABBE19-5895-431A-AC5B-023A76F90647Q40244657-DCD1B652-1FB3-4DC2-A0FD-4F7F904E2C53Q43153440-EFEB273C-D2FC-4273-8633-EB2DD6184A96Q43445195-9FE2F4F5-4D62-45CB-8E37-E7B98009BB65Q44166124-A1404512-9B31-433E-A2F9-477A212EB223Q50119015-0B1DCDCB-B93E-4D62-B948-D6CF99122BA1Q51325887-441CBE6B-84B4-42A0-A9E9-ACB6C29F33FFQ51731739-E4AD80B6-23BA-4761-AAE1-DECC36F5683EQ51806556-A5B7FFDB-62B2-436D-9DAB-591D4A9B5E40Q52282753-E0AECA3C-4A83-4D61-BFC0-EF9A25F6E0C5Q58283772-C08C6552-204E-4B32-8979-3050A8633DCD
P2860
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@ast
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@en
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@nl
type
label
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@ast
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@en
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@nl
prefLabel
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@ast
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@en
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@nl
P2093
P3181
P356
P1433
P1476
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
@en
P2093
A A Strasser
G A Giovino
L T Kozlowski
P A Erickson
P3181
P356
10.1136/TC.10.3.201
P407
P577
2001-09-01T00:00:00Z